Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma

Modern Pathology

Volumn 30, Issue 2, 2017, Pages 267-277

  Bae, Jeong Mo ^a,b   Kim, Jung Ho ^a   Oh, Hyeon Jeong ^a   Park, Hye Eun ^a   Lee, Tae Hun ^c   Cho, Nam Yun ^c   Kang, Gyeong Hoon ^a,c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETATE COENZYME A LIGASE; ACETYL COENZYME A SYNTHETASE 2; B RAF KINASE; CYTOKERATIN 20; CYTOKERATIN 7; FLUOROURACIL; K RAS PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL LIVER METASTASIS; COLORECTAL POLYP; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; ONCOGENESIS AND MALIGNANT TRANSFORMATION; ONCOLOGICAL PARAMETERS; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; SURVIVAL TIME; TUMOR BUDDING; TUMOR DIFFERENTIATION; TUMOR GROWTH; ADENOMA; CARCINOMA; COLON POLYPOSIS; COLORECTAL TUMOR; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR INVASION;

ACETATE-COA LIGASE; ADENOMA; ADENOMATOUS POLYPOSIS COLI; AGED; CARCINOMA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 84990187272     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2016.172     Document Type: Article

References (29)

1. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab 2016; 23: 27-47
2. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11: 85-95
3. Lyssiotis CA, Cantley LC. Acetate fuels the cancer engine. Cell 2014; 159: 1492-1494
4. Pietrocola F, Galluzzi L, Bravo-San Pedro JM, et al. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab 2015; 21: 805-821
5. Wellen KE, Thompson CB. A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 2012; 13: 270-276
6. Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol 2015; 17: 351-359
7. Comerford SA, Huang Z, Du X, et al. Acetate dependence of tumors. Cell 2014; 159: 1591-1602
8. Mashimo T, Pichumani K, Vemireddy V, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 2014; 159: 1603-1614
9. Bae JM, Kim JH, Rhee YY, et al. Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway. World J Gastroenterol 2015; 21: 9749-9757
10. Park SY, Kim BH, Kim JH, et al. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med 2007; 131: 1561-1567
11. Kim JH, Kim KJ, Rhee YY, et al. Gastric-Type expression signature in serrated pathway-Associated colorectal tumors. Hum Pathol 2015; 46: 643-656
12. Bae JM, Lee TH, Cho NY, et al. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. World J Gastroenterol 2015; 21: 1457-1467
13. Kim JH, Shin SH, Kwon HJ, et al. Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch 2009; 455: 485-494
14. Bae JM, Kim JH, Cho NY, et al. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer 2013; 109: 1004-1012
15. Kim JH, Rhee YY, Bae JM, et al. Subsets of microsatellite-unstable colorectal cancers exhibit discordance between the CpG island methylator phenotype and MLH1 methylation status. Mod Pathol 2013; 26: 1013-1022
16. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793
17. Donohoe DR, Collins LB, Wali A, et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 2012; 48: 612-626
18. Schug ZT, Peck B, Jones DT, et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 2015; 27: 57-71
19. Hur H, Kim YB, Ham IH, et al. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer. J Surg Oncol 2015; 112: 585-591
20. Soliman ML, Rosenberger TA. Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression. Mol Cell Biochem 2011; 352: 173-180
21. Marques C, Oliveira CS, Alves S, et al. Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release. Cell Death Dis 2013; 4: e507
22. Allegra CJ, Paik S, Colangelo LH, et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 2003; 21: 241-250
23. Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol 2004; 22: 1572-1582
24. Hilska M, Collan YU, OL VJ, et al. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer. Dis Colon Rectum 2005; 48: 2197-2208
25. Fodor IK, Hutchins GG, Espiritu C, et al. Prognostic and predictive significance of proliferation in 867 colorectal cancers. J Clin Pathol 2012; 65: 989-995
26. Yuen ST, Davies H, Chan TL, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 2002; 62: 6451-6455
27. Nagasaka T, Sasamoto H, Notohara K, et al. Colorectal cancer with mutation in BRAF, KRAS, and wild-Type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 2004; 22: 4584-4594
28. Shin US, Cho SS, Moon SM, et al. Is microsatellite instability really a good prognostic factor of colorectal cancer? Ann Coloproctol 2014; 30: 28-34
29. Jeon CH, Lee HI, Shin IH, et al. Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients. Int J Colorectal Dis 2008; 23: 29-35